{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:58:06Z","timestamp":1792652286751,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T00:00:00Z","timestamp":1549411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T00:00:00Z","timestamp":1549411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["K08 NS083626"],"award-info":[{"award-number":["K08 NS083626"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS089719"],"award-info":[{"award-number":["NS089719"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS076517"],"award-info":[{"award-number":["NS076517"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["IRG-14-188-01"],"award-info":[{"award-number":["IRG-14-188-01"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH096463"],"award-info":[{"award-number":["MH096463"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL118561"],"award-info":[{"award-number":["HL118561"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA138292"],"award-info":[{"award-number":["P30CA138292"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s11060-019-03115-0","type":"journal-article","created":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T12:55:06Z","timestamp":1549457706000},"page":"411-422","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Modulating native GABAA receptors in medulloblastoma with positive allosteric benzodiazepine-derivatives induces cell death"],"prefix":"10.1007","volume":"142","author":[{"given":"Laura","family":"Kallay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Havva","family":"Keskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manali","family":"Rupji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia A.","family":"Moody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanguan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taukir","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farjana","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Rajesh","family":"Stephen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten A.","family":"Cottrill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Austin","family":"Nuckols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxwell","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah E.","family":"Martinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Tranghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxin","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne","family":"Kowalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Pomeranz Krummel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4577-1397","authenticated-orcid":false,"given":"Soma","family":"Sengupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,6]]},"reference":[{"key":"3115_CR1","doi-asserted-by":"publisher","first-page":"490","DOI":"10.12688\/f1000research.10859.1","volume":"6","author":"S Sengupta","year":"2017","unstructured":"Sengupta S, Pomeranz Krummel D, Pomeroy S (2017) The evolution of medulloblastoma therapy to personalized medcine. F1000Research 6:490. \n                    https:\/\/doi.org\/10.12688\/f1000research.10859.1","journal-title":"F1000Research"},{"key":"3115_CR2","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1200\/JCO.2017.73.0242","volume":"35","author":"D Sturm","year":"2017","unstructured":"Sturm D, Pfister SM, Jones DTW (2017) Pediatric gliomas: current concepts on diagnosis, biology, and clinical management. J Clin Oncol 35:2370\u20132377. \n                    https:\/\/doi.org\/10.1200\/JCO.2017.73.0242","journal-title":"J Clin Oncol"},{"key":"3115_CR3","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.trsl.2017.08.001","volume":"188","author":"BL Marini","year":"2017","unstructured":"Marini BL, Benitez LL, Zureick AH, Salloum R, Gauthier AC, Brown J et al (2017) Blood\u2013brain barrier-adapted precision medicine therapy for pediatric brain tumors. Transl Res 188:e1\u2013e27. \n                    https:\/\/doi.org\/10.1016\/j.trsl.2017.08.001","journal-title":"Transl Res"},{"key":"3115_CR4","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s11095-013-1196-z","volume":"31","author":"L Wu","year":"2014","unstructured":"Wu L, Li X, Janagam DR, Lowe TL (2014) Overcoming the blood\u2013brain barrier in chemotherapy treatment of pediatric brain tumors. Pharm Res 31:531\u2013540. \n                    https:\/\/doi.org\/10.1007\/s11095-013-1196-z","journal-title":"Pharm Res"},{"key":"3115_CR5","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/S1470-2045(17)30243-7","volume":"18","author":"EC Schwalbe","year":"2017","unstructured":"Schwalbe EC, Lindsey JC, Nakjang S, Crosier S, Smith AJ, Hicks D et al (2017) Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study. Lancet Oncol 18:958\u2013971. \n                    https:\/\/doi.org\/10.1016\/S1470-2045(17)30243-7","journal-title":"Lancet Oncol"},{"key":"3115_CR6","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1200\/JCO.2010.28.5148","volume":"29","author":"YJ Cho","year":"2011","unstructured":"Cho YJ, Tsherniak A, Tamayo P, Santagata S, Ligon A, Greulich H et al (2011) Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome. J Clin Oncol 29:1424\u20131430. \n                    https:\/\/doi.org\/10.1200\/JCO.2010.28.5148","journal-title":"J Clin Oncol"},{"key":"3115_CR7","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1200\/JCO.2009.27.4324","volume":"29","author":"PA Northcott","year":"2011","unstructured":"Northcott PA, Korshunov A, Witt H, Hielscher T, Eberhart CG, Mack S et al (2011) Medulloblastoma comprises four distinct molecular variants. J Clin Oncol 29:1408\u20131414. \n                    https:\/\/doi.org\/10.1200\/JCO.2009.27.4324","journal-title":"J Clin Oncol"},{"key":"3115_CR8","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00401-012-0958-8","volume":"123","author":"M Kool","year":"2012","unstructured":"Kool M, Korshunov A, Remke M, Jones DTW, Schlanstein M, Northcott PA et al (2012) Molecular subgroups of medulloblastoma: a international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas. Acta Neuropathol 123:473\u2013484. \n                    https:\/\/doi.org\/10.1007\/s00401-012-0958-8","journal-title":"Acta Neuropathol"},{"key":"3115_CR9","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nature11327","volume":"488","author":"PA Northcott","year":"2012","unstructured":"Northcott PA, Shih DJ, Peacock J, Garzia L, Morrissy AS, Zichner T et al (2012) Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature 488:49\u201356. \n                    https:\/\/doi.org\/10.1038\/nature11327","journal-title":"Nature"},{"key":"3115_CR10","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nature11329","volume":"488","author":"TJ Pugh","year":"2012","unstructured":"Pugh TJ, Weeraratne SD, Archer TC, Pomeranz Krummel DA, Auclair D, Bochicchio J et al (2012) Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations within a broad landscape of genetic heterogeneity. Nature 488:106\u2013110. \n                    https:\/\/doi.org\/10.1038\/nature11329","journal-title":"Nature"},{"key":"3115_CR11","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.ccell.2017.05.005","volume":"31","author":"FMG Cavalli","year":"2017","unstructured":"Cavalli FMG, Remke M, Rampasek L, Peacock J, Shi DJH, Luu B et al (2017) Intertumoral heterogeneity within medulloblastoma subgroups. Cancer Cell 31:737\u2013754. \n                    https:\/\/doi.org\/10.1016\/j.ccell.2017.05.005","journal-title":"Cancer Cell"},{"key":"3115_CR12","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s11060-011-0648-8","volume":"106","author":"M Gessi","year":"2012","unstructured":"Gessi M, von Bueren AO, Rutkowski S, Pietsch T (2012) p53 expression predicts dismal outcome for medulloblastoma patients with metastatic disease. J Neuro Oncol 106:135\u2013141. \n                    https:\/\/doi.org\/10.1007\/s11060-011-0648-8","journal-title":"J Neuro Oncol"},{"key":"3115_CR13","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nature22973","volume":"547","author":"PA Northcott","year":"2017","unstructured":"Northcott PA, Buchhalter I, Morrissy AS, Hovestadt V, Weischenfeldt J, Ehrenberger T et al (2017) The whole-genome landscape of medulloblastoma subtypes. Nature 547:311\u2013317. \n                    https:\/\/doi.org\/10.1038\/nature22973","journal-title":"Nature"},{"key":"3115_CR14","doi-asserted-by":"publisher","first-page":"40224","DOI":"10.1074\/jbc.R112.386664","volume":"287","author":"E Sigel","year":"2012","unstructured":"Sigel E, Steinmann ME (2012) Structure, function, and modulation of GABAA receptors. J Biol Chem 287:40224\u201340231. \n                    https:\/\/doi.org\/10.1074\/jbc.R112.386664","journal-title":"J Biol Chem"},{"key":"3115_CR15","doi-asserted-by":"publisher","first-page":"4130","DOI":"10.1021\/jm980317y","volume":"41","author":"Q Huang","year":"1998","unstructured":"Huang Q, Liu R, Zhang P, He X, McKernan R, Gan T, Bennett DW, Cook JM (1998) Predictive models for GABAA\/benzodiazepine receptor subtypes: studies of quantitative structure \u2013 activity relationships for imidazobenzodiazepines at five recombinant GABAA\/benzodiazepine receptor subtypes [\u03b1x\u03b23\u03b32 (x\u2009=\u20091\u20133, 5, and 6)] via comparative molecular field analysis. J Med Chem 41:4130\u20134142. \n                    https:\/\/doi.org\/10.1021\/jm980317y","journal-title":"J Med Chem"},{"key":"3115_CR16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1021\/jm990341r","volume":"43","author":"Q Huang","year":"2000","unstructured":"Huang Q, He X, Ma C, Liu R, Yu S, Dayer CA, Wenger GR, McKernan R, Cook JM (2000) Pharmacophore\/receptor models for GABA(A)\/BzR subtypes (alpha1beta3gamma2, alpha5beta3gamma2, and alpha6beta3gamma2) via a comprehensive ligand-mapping approach. J Med Chem 43:71\u201395. \n                    https:\/\/doi.org\/10.1021\/jm990341r","journal-title":"J Med Chem"},{"key":"3115_CR17","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00401-013-1205-7","volume":"127","author":"S Sengupta","year":"2014","unstructured":"Sengupta S, Weeraratne SD, Sun H, Phallen J, Rallapalli SK, Teider N et al (2014) \u03b15-GABAA receptors negatively regulate MYC-amplified medulloblastoma growth. Acta Neuropathol 127:593\u2013603. \n                    https:\/\/doi.org\/10.1007\/s00401-013-1205-7","journal-title":"Acta Neuropathol"},{"key":"3115_CR18","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1166\/jbn.2016.2262","volume":"12","author":"O Jonas","year":"2016","unstructured":"Jonas O, Calligaris D, Methuku KR, Poe MM, Francois JP, Tranghese F et al (2016) First in vivo testing of compounds targeting Group 3 medulloblastoma using an implantable microdevice as a new paradigm for drug development. J Biomed Nanotechnol 12:1297\u20131302. \n                    https:\/\/doi.org\/10.1166\/jbn.2016.2262","journal-title":"J Biomed Nanotechnol"},{"key":"3115_CR19","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1158\/1078-0432.CCR-13-2281","volume":"20","author":"P Bandopadhayay","year":"2014","unstructured":"Bandopadhayay P, Bergthold G, Nguyen B, Schubert S, Gholamin S, Tang Y et al (2014) BET bromodomain inhibition of MYC-amplified medulloblastoma. Clin Cancer Res 20:912\u2013925. \n                    https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-2281","journal-title":"Clin Cancer Res"},{"key":"3115_CR20","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1093\/neuonc\/nou234","volume":"17","author":"RY Bai","year":"2015","unstructured":"Bai RY, Staedtke V, Rudin CM, Bunz F, Riggins GJ (2015) Effective treatment of diverse medulloblastoma models with mebendazole and its impact on tumor angiogenesis. Neuro Oncol 17:545\u2013554. \n                    https:\/\/doi.org\/10.1093\/neuonc\/nou234","journal-title":"Neuro Oncol"},{"key":"3115_CR21","unstructured":"Cook JM, Huang Q, He X, Li X, Yu J, Han D, Lelas S, McElroy JF (2006) US Patent 7119196 B2"},{"key":"3115_CR22","unstructured":"Cook JM, Huang S, Edwankar R, Namjoshi OA, Wang ZJ (2014) US Patent 8835424 B2"},{"key":"3115_CR23","doi-asserted-by":"publisher","first-page":"7281","DOI":"10.1074\/jbc.M109.050294","volume":"285","author":"CA Williams","year":"2010","unstructured":"Williams CA, Bell SV, Jenkins A (2010) A residue in loop 9 of the beta2-subunit stabilizes the closed state of the GABAA receptor. J Biol Chem 285:7281\u20137287. \n                    https:\/\/doi.org\/10.1074\/jbc.M109.050294","journal-title":"J Biol Chem"},{"key":"3115_CR24","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1097\/00005072-198509000-00003","volume":"44","author":"PF Jacobsen","year":"1985","unstructured":"Jacobsen PF, Jenkyn DJ, Papadimitriou JM (1985) Establishment of a human medulloblastoma cell line and its heterotransplantation into nude mice. J Neuropathol Exp Neurol 44:472\u2013485","journal-title":"J Neuropathol Exp Neurol"},{"key":"3115_CR25","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1097\/00005072-198511000-00005","volume":"44","author":"HS Friedman","year":"1985","unstructured":"Friedman HS, Burger PC, Bigner SH, Trojanowski JQ, Wikstrand CJ, Halperin EC, Bigner DD (1985) Establishment and characterization of the human medulloblastoma cell line and transplantable xenograft D283. Med J Neuropathol Exp Neurol 44:592\u2013605","journal-title":"Med J Neuropathol Exp Neurol"},{"key":"3115_CR26","first-page":"2347","volume":"50","author":"SH Bigner","year":"1990","unstructured":"Bigner SH, Friedman HS, Vogelstein B, Oakes WJ, Bigner DD (1990) Amplification of the c-myc gene in human medulloblastoma cell lines and xenografts. Cancer Res 50:2347\u20132350","journal-title":"Cancer Res"},{"key":"3115_CR27","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.2174\/092986707782360097","volume":"14","author":"T Clayton","year":"2007","unstructured":"Clayton T, Chen JL, Ernst M, Richter L, Cromer BA, Morton CJ et al (2007) An updated unified pharmacophore model of the benzodiazepine binding site on gamma-aminobutyric acid(a) receptors: correlation with comparative models. Curr Med Chem 14:2755\u20132775. \n                    https:\/\/doi.org\/10.2174\/092986707782360097","journal-title":"Curr Med Chem"},{"key":"3115_CR28","doi-asserted-by":"publisher","first-page":"430248","DOI":"10.1155\/2015\/430248","volume":"2015","author":"T Clayton","year":"2015","unstructured":"Clayton T, Poe MM, Rallapalli S, Biawat P, Savi\u0107 MM, Rowlett JK et al (2015) A review of the updated pharmacophore for the alpha 5 GABA (A) benzodiazepine receptor model. Int J Med Chem 2015:430248. \n                    https:\/\/doi.org\/10.1155\/2015\/430248","journal-title":"Int J Med Chem"},{"key":"3115_CR29","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1002\/j.1460-2075.1982.tb01321.x","volume":"1","author":"B Maro","year":"1982","unstructured":"Maro B, Marty MC, Bornens M (1982) In vivo and in vitro effects of the mitochondrial uncoupler FCCP on microtubules. EMBO J 1:1347\u20131352","journal-title":"EMBO J"},{"key":"3115_CR30","doi-asserted-by":"publisher","first-page":"270","DOI":"10.2174\/156802612799078720","volume":"12","author":"B Costa","year":"2012","unstructured":"Costa B, Da Pozzo E, Martini C (2012) Translocator protein as a promising target for novel anxiolytics. Curr Top Med Chem 12:270\u2013285. \n                    https:\/\/doi.org\/10.1111\/j.1365-2826.2011.02166.x","journal-title":"Curr Top Med Chem"},{"key":"3115_CR31","doi-asserted-by":"publisher","first-page":"5851","DOI":"10.1158\/0008-5472.CAN-09-4646","volume":"70","author":"F Zhu","year":"2010","unstructured":"Zhu F, Doll\u00e9 ME, Berton TR, Kuiper RV, Capps C, Espejo A et al (2010) Mouse models for the p53 R72P polymorphism mimic human phenotypes. Cancer Res 70:5851\u20135859. \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-4646","journal-title":"Cancer Res"},{"key":"3115_CR32","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1080\/15384101.2017.1312234","volume":"16","author":"ER Dom\u00ednguez","year":"2017","unstructured":"Dom\u00ednguez ER, Orona J, Lin K, P\u00e9rez CJ, Benavides F, Kusewitt DF, Johnson DG (2017) The p53 R72P polymorphism does not affect the physiological response to ionizing radiation in a mouse model. Cell Cycle 16:1153\u20131163. \n                    https:\/\/doi.org\/10.1080\/15384101.2017.1312234","journal-title":"Cell Cycle"},{"key":"3115_CR33","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1042\/BST20140070","volume":"42","author":"AG Abraham","year":"2014","unstructured":"Abraham AG, O\u2019Neill E (2014) PI3K\/Akt-mediated regulation of p53 in cancer. Biochem Soc Trans 42:798\u2013803. \n                    https:\/\/doi.org\/10.1042\/BST20140070","journal-title":"Biochem Soc Trans"},{"key":"3115_CR34","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.tcb.2008.01.007","volume":"18","author":"JE Chipuk","year":"2008","unstructured":"Chipuk JE, Green DR (2008) How do BCL-2 proteins induce mitochondrial outer membrane permeabilization? Trends Cell Biol 18:157\u2013164. \n                    https:\/\/doi.org\/10.1016\/j.tcb.2008.01.007","journal-title":"Trends Cell Biol"},{"key":"3115_CR35","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1023\/B:APPT.0000025810.58981.4c","volume":"9","author":"JF Charlot","year":"2004","unstructured":"Charlot JF, Pr\u00e9tet JL, Haughey C, Mougin C (2004) Mitochondrial translocation of p53 and mitochondrial membrane potential (Delta Psi m) dissipation are early events in staurosporine-induced apoptosis of wild type and mutated p53 epithelial cells. Apoptosis 9:333\u2013343. \n                    https:\/\/doi.org\/10.1023\/B:APPT.0000025810.58981.4c","journal-title":"Apoptosis"},{"key":"3115_CR36","doi-asserted-by":"publisher","first-page":"3519","DOI":"10.4161\/cc.8.21.9888","volume":"8","author":"DJ Blackiston","year":"2009","unstructured":"Blackiston DJ, McLaughlin KA, Levin M (2009) Bioelectric controls of cell proliferation: ion channels, membrane voltage and the cell cycle. Cell Cycle 8:3519\u20133528. \n                    https:\/\/doi.org\/10.4161\/cc.8.21.9888","journal-title":"Cell Cycle"},{"key":"3115_CR37","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S0955-0674(00)00228-3","volume":"13","author":"SP Yu","year":"2001","unstructured":"Yu SP, Canzoniero LM, Choi DW (2001) Ion homeostasis and apoptosis. Curr Opin Cell Biol 13:405\u2013411. \n                    https:\/\/doi.org\/10.1016\/S0955-0674(00)00228-3","journal-title":"Curr Opin Cell Biol"},{"key":"3115_CR38","doi-asserted-by":"publisher","first-page":"10117","DOI":"10.1021\/bi970759w","volume":"36","author":"K Sakaguchi","year":"1997","unstructured":"Sakaguchi K, Sakamoto H, Lewis MS, Anderson CW, Erickson JW, Appella E, Xie D (1997) Phosphorylation of serine 392 stabilizes the tetramer formation of tumor suppressor protein p53. Biochemistry 36:10117\u201310124. \n                    https:\/\/doi.org\/10.1021\/bi970759w","journal-title":"Biochemistry"},{"key":"3115_CR39","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1111\/IGC.0b013e3181b70465","volume":"19","author":"JK Bar","year":"2009","unstructured":"Bar JK, S\u0142omska I, Rabczy\u0144ki J, Noga L, Grybo\u015b M (2009) Expression of p53 protein phosphorylated at serine 20 and serine 392 in malignant and benign ovarian neoplasms: correlation with clinicopathological parameters of tumors. Int J Gynecol Cancer 19:1322\u20131328. \n                    https:\/\/doi.org\/10.1111\/IGC.0b013e3181b70465","journal-title":"Int J Gynecol Cancer"},{"key":"3115_CR40","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.3892\/or.12.5.1039","volume":"12","author":"M Matsumoto","year":"2004","unstructured":"Matsumoto M, Furihata M, Kurabayashi A, Ohtsuki Y (2004) Phosphorylation state of tumor-suppressor gene p53 product overexpressed in skin tumors. Oncol Rep 12:1039\u20131043. \n                    https:\/\/doi.org\/10.3892\/or.12.5.1039","journal-title":"Oncol Rep"},{"key":"3115_CR41","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1159\/000081001","volume":"67","author":"M Matsumoto","year":"2004","unstructured":"Matsumoto M, Furihata M, Kurabayashi A, Sasaguri S, Araki K, Hayashi H, Ohtsuki Y (2004) Prognostic significance of serine 392 phosphorylation in overexpressed p53 protein in human esophageal squamous cell carcinoma. Oncology 67:143\u2013150. \n                    https:\/\/doi.org\/10.1159\/000081001","journal-title":"Oncology"},{"key":"3115_CR42","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1152\/physiol.00002.2009","volume":"24","author":"SZ Young","year":"2009","unstructured":"Young SZ, Bordey A (2009) GABA\u2019s control of stem and cancer cell proliferation in adult neural and peripheral niches. Physiology 24:171\u2013185. \n                    https:\/\/doi.org\/10.1152\/physiol.00002.2009","journal-title":"Physiology"},{"key":"3115_CR43","doi-asserted-by":"publisher","first-page":"e37041","DOI":"10.1371\/journal.pone.0037041","volume":"7","author":"A Smits","year":"2012","unstructured":"Smits A, Jin Z, Elsir T, Pedder H, Nist\u00e9r M, Alafuzoff I et al (2012) GABA-A channel subunit expression in human glioma correlates with tumor histology and clinical outcome. PLoS ONE 7:e37041. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0037041","journal-title":"PLoS ONE"},{"key":"3115_CR44","doi-asserted-by":"publisher","first-page":"10715","DOI":"10.1038\/ncomms10715","volume":"7","author":"K Gumireddy","year":"2016","unstructured":"Gumireddy K, Li A, Kossenkov AV, Sakurai M, Yan J, Li Y, Xu H, Wang J, Zhang PJ, Zhang L, Showe LC, Nishikura K, Huang Q (2016) The mRNA-edited form of GABRA3 suppresses GABRA3-mediated Akt activation and breast cancer metastasis. Nat Commun 7:10715. \n                    https:\/\/doi.org\/10.1038\/ncomms10715","journal-title":"Nat Commun"},{"key":"3115_CR45","doi-asserted-by":"publisher","first-page":"32341","DOI":"10.18632\/oncotarget.8700","volume":"7","author":"L Liu","year":"2016","unstructured":"Liu L, Yang C, Shen J, Huang L, Lin W, Tang H, Liang W, Shao W, Zhang H, He J (2016) GABRA3 promotes lymphatic metastasis in lung adenocarcinoma by mediating upregulation of matrix metalloproteinases. Oncotarget 7:32341\u201332350. \n                    https:\/\/doi.org\/10.18632\/oncotarget.8700","journal-title":"Oncotarget"},{"key":"3115_CR46","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12943-017-0723-7","volume":"16","author":"M Long","year":"2017","unstructured":"Long M, Zhan M, Xu S, Yang R, Chen W, Zhang S, Shi Y, He Q, Mohan M, Liu Q, Wang J (2017) miR-92b-3p acts as a tumor suppressor by targeting Gabra3 in pancreatic cancer. Mol Cancer 16:167. \n                    https:\/\/doi.org\/10.1186\/s12943-017-0723-7","journal-title":"Mol Cancer"},{"key":"3115_CR47","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1016\/j.bbamem.2015.03.034","volume":"1848","author":"VP Kale","year":"2015","unstructured":"Kale VP, Amin SG, Pandey MK (2015) Targeting ion channels for cancer therapy by repurposing the approved drugs. Biochem Biophys Acta 1848:2747\u20132755. \n                    https:\/\/doi.org\/10.1016\/j.bbamem.2015.03.0347","journal-title":"Biochem Biophys Acta"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-019-03115-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-019-03115-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-019-03115-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T07:33:25Z","timestamp":1589700805000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-019-03115-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,6]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["3115"],"URL":"https:\/\/doi.org\/10.1007\/s11060-019-03115-0","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,6]]},"assertion":[{"value":"2 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare they have no conflict of interest with the present study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}